UV Disinfection Equipment Market By Component (UV Lamps, Quartz Sleeves, Ballasts/Controllers, Reactor Chambers, Others); By Application (Water & Wastewater Disinfection, Air Disinfection, Surface Disinfection, Food & Beverage Disinfection); By End User (Municipal, Industrial, Healthcare, Commercial, Residential); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

UV Disinfection Equipment Market: Water Reuse and Validated Dose Control Shift Revenue from UV Lamps to Treatment Platforms

The Global UV Disinfection Equipment Market is estimated to reach USD 5.34 billion in 2025 and is projected to grow to USD 11.30 billion by 2032, expanding at a CAGR of 11.3%, supported by UV-C disinfection adoption across water treatment plants, air purification devices, medical sterilization, surface hygiene, and infection prevention technologies, according to Strategic Market Research.

 

Municipal and industrial Operators no longer assess UV disinfection systems as standalone lamp purchases. Utilities now evaluate validated dose delivery, energy use, hydraulic capacity, fouling control, replacement-part availability, and service support across the reactor’s operating life. Industrial customers apply similar criteria, weighing production downtime, contamination risk, membrane protection, and water-reuse savings. As a result, revenue is shifting toward integrated treatment platforms that combine reactors, sensors, automated cleaning, controls, remote monitoring, validation, replacement lamps or LED modules, and long-term maintenance.

 

Water treatment represents the market’s largest infrastructure base. Drinking-water plants use UV as an added microbial barrier, while wastewater facilities deploy open-channel and closed-vessel systems before discharge or reuse. Food and beverage, pharmaceutical, semiconductor, power-generation, aquaculture, and other industrial facilities use UV to protect process water and reduce reliance on chemical treatment. Air, surface, room, and equipment-disinfection systems broaden the market across healthcare, controlled manufacturing, commercial buildings, and food-processing environments, although these products follow distinct purchasing and regulatory pathways.

 

Trojan Technologies reported reaching 10,000 municipal UV installations in 2016. Atlantium disclosed more than 5,200 installations worldwide as of 2026. Nuvonic reports thousands of installations in more than 100 countries, while De Nora states that its UV portfolio has an installed treatment capacity of 24,374 million litres per day and serves approximately 38 million people. These figures overlap neither consistently nor transparently enough to produce a global total, but they establish a large installed base for replacement lamps, sleeves, sensors, controls, upgrades, and service contracts.

 

Five UV Technologies Compete for Different Operating Conditions

The market can be classified into five principal UV source technologies, although no global standard mandates a fixed number of equipment categories.

• Low-pressure mercury lamps produce concentrated UV output near 254 nanometres and remain common in lower-flow drinking-water, industrial, residential, and commercial systems. Their established validation history and energy efficiency support continued use where plant footprint is not the overriding constraint.

• Low-pressure high-output and amalgam lamps increase output per lamp and reduce the number of emitters required for larger flows. They are widely used in municipal drinking water, wastewater, reuse, and industrial installations where buyers seek lower energy use than medium-pressure systems without accepting a large reactor footprint.

• Medium-pressure mercury lamps deliver higher output across a broader wavelength range. Their compact configuration suits high-capacity plants, retrofit projects with limited space, swimming pools, advanced oxidation, and applications where a small number of high-powered lamps simplifies reactor design.

• Pulsed-xenon systems generate high-intensity, broad-spectrum pulses. Their strongest commercial position is in healthcare rooms, surfaces, packaging lines, and enclosed equipment applications rather than continuous-flow municipal water treatment.

• UV-C LEDs provide instant activation, modularity, wavelength selection, and mercury-free operation. LEDs are established in appliances, dispensers, point-of-use water systems, laboratories, and intermittent-flow equipment. Third-party validation is now allowing the technology to move into larger industrial and municipal specifications.

These five sources are deployed through at least six major equipment configurations: pressurized closed-vessel reactors, open-channel wastewater systems, point-of-entry and point-of-use water units, upper-room and in-duct air systems, mobile or stationary whole-room units, and enclosed or conveyor-based disinfection chambers. The source type and equipment configuration are separate classifications. A medium-pressure lamp, for example, can operate inside a closed-vessel drinking-water reactor, a pool system, or an advanced-oxidation unit.

Conventional mercury lamps retain an advantage in validated operating experience and large-scale output. EPA’s drinking-water guidance cites historical design-life benchmarks of approximately 12,000 hours for low-pressure and low-pressure high-output lamps and 8,000 hours for medium-pressure lamps. Actual replacement intervals vary by manufacturer, power cycling, water temperature, fouling, and operating policy. The commercial consequence is recurring component revenue and a strong incentive for utilities to standardize around suppliers that can guarantee lamp availability over a reactor’s multi-year service life.

 

Drinking-Water Investment Creates a Large but Selective Project Pipeline

WHO and UNICEF reported that 2.1 billion people lacked safely managed drinking-water services in 2024, including 106 million people who obtained water directly from untreated surface sources. UV equipment addresses only part of this deficit. Many underserved communities require abstraction, filtration, pumping, storage, distribution, and reliable power before UV becomes technically or economically viable. The commercially relevant opportunity therefore lies in funded municipal plants, decentralized community systems, commercial point-of-entry units, and packaged treatment installations rather than a direct one-system-per-unserved-person calculation.

Mature markets offer a more immediate replacement and modernization opportunity. EPA estimates that U.S. drinking-water systems need USD 625 billion in infrastructure investment over 20 years. UV will capture a limited share of this expenditure because the estimate includes pipes, storage, treatment facilities, and other assets. Treatment-plant rehabilitation still creates a substantial specification pipeline for reactors, controls, advanced oxidation, validation, and aftermarket support.

Regulatory treatment credit raises the entry barrier. U.S. public water systems seeking UV disinfection credit must submit reactor-validation results demonstrating that the required dose is achieved under the proposed operating conditions. Flow, UV transmittance, lamp status, sensor response, sleeve condition, and hydraulic behaviour affect the validated envelope. A supplier with a higher-power lamp but a weak validation package can lose against a lower-power system that provides a wider operating range and stronger compliance documentation.

UV also has a defined limitation: it does not maintain a disinfectant residual throughout storage and distribution. Utilities often retain chlorine or chloramine downstream of UV. The addressable market is therefore not based on replacing all chemical disinfection. UV earns its position where it provides effective control of organisms such as Cryptosporidium and Giardia, reduces pressure to increase primary chlorine dosage, or supports a multi-barrier treatment strategy without materially adding regulated chlorinated by-products.

 

Wastewater Spending Favors Systems That Lower Compliance Risk

EPA’s 2022 Clean Watersheds Needs Survey identified at least USD 630 billion in U.S. wastewater, stormwater, decentralized-treatment, and related infrastructure requirements over 20 years. The expenditure includes far more than disinfection, but treatment-plant upgrades create demand for high-capacity UV systems when utilities replace chlorine contact basins, expand peak-flow capacity, or prepare effluent for reuse.

Global industrial wastewater data reveal an additional but poorly measured opportunity. UN-Water’s 2024 update found that only 38% of industrial wastewater was reported as treated and 27% as safely treated across the 22 reporting countries. Those countries represented just 8% of the global population, so the figures cannot be generalized into a worldwide treatment rate. The limited reporting itself raises the commercial importance of monitoring, auditability, and verified performance as governments impose stronger industrial-discharge requirements.

Wastewater projects are won on delivered dose under adverse conditions, not on nominal lamp output. Suspended solids, variable UV transmittance, peak flow, sleeve fouling, and upstream process instability can reduce performance. Buyers place greater value on automated sleeve cleaning, real-time intensity measurement, flow pacing, lamp dimming, hydraulic validation, redundancy, and rapid maintenance access. These features increase the original equipment price but can reduce electricity use, prevent permit violations, and avoid plant bypasses.

Atlantium’s November 2025 launch of next-generation open-channel UV systems shows specialist suppliers targeting reuse and stricter wastewater standards rather than remaining concentrated in closed-vessel industrial systems. The company also introduced annual service packages designed around more than 99.5% system availability and secured U.S. validation for its open-channel platform. Packaging availability as a contractual service shifts part of the buying decision from capital price toward uptime and verified treatment performance.

Nuvonic’s OpenLine systems follow the same competitive direction. Their control architecture adjusts lamp power using output, water-quality, and flow measurements. The commercial benefit is not simply lower electricity consumption. Dynamic operation allows a plant to avoid dosing for permanent worst-case conditions during periods of higher UV transmittance or lower flow, improving the lifecycle economics used in public tenders.

 

Water Reuse Increases Equipment Value per Project

Water reuse changes UV from a final discharge step into a critical barrier within an advanced treatment train. Reuse facilities commonly combine filtration, membranes, reverse osmosis, UV, advanced oxidation, activated carbon, and chemical conditioning. The UV system must control pathogens and, in advanced-oxidation applications, support the destruction of selected chemical contaminants after membrane treatment.

The European Union’s recast Urban Wastewater Treatment Directive entered into force in January 2025. It expands collection and treatment obligations, introduces quaternary treatment requirements for micropollutants, promotes reuse of treated wastewater, and moves large treatment systems toward energy neutrality. UV is not prescribed as the universal solution, but the directive increases competition for tertiary disinfection and advanced-oxidation projects. It also raises energy efficiency from a secondary product feature to a procurement constraint because plants must add treatment capacity without undermining energy-neutrality targets.

Xylem’s sequential ozone-and-UV system for Dutch utility Dunea reportedly reduces organic micropollutants by as much as 90% in water serving more than 1.3 million people. The installation demonstrates how UV suppliers can move beyond microbial disinfection into higher-value contaminant-removal projects. Competition in this segment depends on removal performance, oxidant consumption, bromate or by-product control, electricity use, and integration with the rest of the plant.

Trojan Technologies supplied UV advanced oxidation to Europe’s first potable-reuse demonstration facility at Roses, Spain. The pilot became operational in January 2025 and is evaluating a treatment train that includes ultrafiltration, reverse osmosis, UV, activated carbon, and remineralization. Demonstration projects are commercially important because utilities rarely move directly from laboratory evidence to full-scale potable reuse. Suppliers that establish pilots can influence the final design basis, validation protocol, and replacement-component specification before procurement begins.

 

Industrial Customers Pay for Production Protection, Not Only Disinfection

Industrial UV adoption is strongest where poor water quality can interrupt production, damage yield, contaminate products, or shorten membrane life. Food and beverage plants treat ingredient water, process water, recovered condensate, rinse water, sugar solutions, and packaging surfaces. Pharmaceutical plants use UV for microbial control, ozone destruction, dechlorination, and total-organic-carbon reduction in purified-water systems. Semiconductor facilities require exceptionally low organic contamination because trace impurities can affect production yield.

The industrial segment typically supports higher engineering and documentation value per unit than standard residential equipment. Pharmaceutical and semiconductor customers require hygienic materials, validated performance, alarm histories, audit trails, calibration, spare-part assurance, and rapid technical support. A low-cost reactor can become commercially unacceptable when an unplanned shutdown costs more than the complete UV installation.

Atlantium reports that its equipment treats more than 40 million gallons of Pasteurized Milk Ordinance-compliant water per day in dairy and food applications. The figure is supplier-reported rather than an independent market total, but it demonstrates how UV can move from ancillary sanitation equipment into high-throughput process infrastructure. Once specified across production lines, replacement components and service become embedded operating expenditures rather than discretionary purchases.

Nuvonic completed the consolidation of Hanovia, Aquionics, Berson, and Orca under one brand in 2025. The combination created one portfolio across water, air, and surface applications and added common remote services, documentation, and supply-chain support. The strategic purpose is to serve multinational food, pharmaceutical, and industrial accounts that prefer one approved supplier across plants and regions. Brand consolidation also improves the company’s ability to cross-sell surface and air systems into customers that already use its water-treatment equipment.

 

UV-C LED Certification Reduces Adoption Risk

UV-C LEDs have long offered instant switching and compact installation, but municipal adoption remained constrained by output, efficiency, thermal management, price, and limited large-flow validation. Utilities do not purchase mercury-free claims alone. They need evidence that an LED reactor can deliver the required dose throughout its expected operating range at an acceptable lifecycle cost.

AquiSense’s PearlAqua Kilo achieved NSF/ANSI/CAN 61-2024 certification and completed validation under EPA’s UV Disinfection Guidance Manual in 2025. The company positions the Kilo and Tera platforms for municipal and industrial flows, with replaceable emitter modules and standardized controls. Certification reduces specification risk for consultants and utilities because it addresses material safety and validated performance rather than relying on laboratory LED-output data.

LED systems are most competitive where intermittent operation avoids unnecessary lamp-on hours, compactness has measurable value, or mercury elimination is an explicit procurement objective. Conventional lamps remain stronger in many continuous high-flow applications because their economics and validation history are well established. The near-term market is therefore a technology mix rather than a rapid market-wide substitution.

 

Acquisitions Show Where Established Suppliers See Unfilled Demand

Veralto agreed to acquire Austrian UV company AQUAFIDES for approximately USD 20 million in February 2025, and AQUAFIDES joined Trojan Technologies in May. AQUAFIDES specializes in small- and medium-sized closed-vessel systems certified for European drinking-water requirements. The acquisition fills a specific portfolio gap: Trojan already had strong large municipal, industrial, membrane, and residential brands, but needed wider European coverage in lower-flow municipal systems.

The transaction also shows why technical certification and installed service access can be worth more than proprietary lamp hardware alone. European drinking-water markets require country-appropriate validation, local engineering relationships, and regional after-sales capability. Acquiring an established platform allows Veralto to shorten the time required to develop those channels organically.

Trojan also began shipping from a new Grand Rapids distribution centre in February 2025. The facility is intended to expand and stabilize fulfilment for U.S. customers. Parts availability is strategically important because municipal systems can remain in operation for decades. Suppliers that cannot provide compatible lamps, sleeves, sensors, and control components risk losing replacement revenue to third-party providers or being excluded from future tenders.

De Nora’s June 2026 selection for the Johor River Waterworks upgrade provides another important market signal. The company’s Sentinel medium-pressure UV system was selected for a 2027 installation because it could be retrofitted into the existing infrastructure with a smaller footprint and longer lamp life. The project shows that the replacement market will not always involve rebuilding complete treatment trains. Compact retrofit systems can capture budgets by extending existing civil assets and reducing installation disruption.

 

Healthcare and Air Disinfection Require a Separate Commercial Model

Healthcare UV equipment remains a specialist segment within the broader market. Whole-room systems, upper-room UVGI, HVAC installations, and enclosed equipment chambers are purchased through infection-prevention, environmental-services, facilities, and capital budgets. They are not treatment products reimbursed according to patient procedures.

The U.S. FDA created a Class II whole-room microbial-reduction category in 2023 and cleared a subsequent entrant in 2025. A nine-hospital implementation study completed UV deployment in 16,220 of 18,411 eligible room discharges, an 88% utilization rate. These developments shift competition toward authorized claims, completed-cycle documentation, safety controls, and workflow integration. A hospital receives little value from a high-output unit that cannot be deployed before the next patient enters the room.

Air disinfection has a stronger facilities-engineering pathway. ASHRAE Standard 241 includes germicidal ultraviolet within equivalent-clean-air strategies, while ANSI/ASHRAE Standard 185.4-2024 establishes a method for testing in-room UV systems intended for surface microbial inactivation. Standards increase the value of tested performance and reduce the credibility of products sold through unsupported germicidal claims.

 

Installed-Base Monetization Will Determine Supplier Quality

Initial equipment orders remain irregular because municipal projects depend on funding, engineering design, permits, and tender cycles. Suppliers reduce this volatility through genuine replacement parts, preventive maintenance, validation, sensor calibration, software, remote diagnostics, and system upgrades.

Nuvonic’s remote-service strategy allows engineers to review control-panel conditions, adjust settings, identify maintenance requirements, and conduct system health checks without an immediate site visit. Atlantium’s annual packages target more than 99.5% availability. These offers convert technical support from a reactive cost centre into a recurring revenue product. They also create customer data and operating relationships that make it harder for competitors to displace the original manufacturer during replacement cycles.

Aftermarket strength will vary by technology. Mercury systems create predictable lamp and sleeve replacement demand. LED platforms may extend replacement intervals in intermittent applications but move revenue into proprietary modules, power electronics, thermal-management components, and controls. Open-channel plants require wipers, sensors, ballasts, and on-site service, while advanced-oxidation systems add oxidant dosing, process monitoring, and integration support.

 

Market Growth Will Be Selective Rather than Uniform

Three commercial conditions will determine whether an addressable facility becomes an actual UV equipment customer.

First, upstream water quality must allow the required UV dose to reach the target organism or contaminant. High turbidity, low transmittance, suspended solids, colour, and sleeve fouling can increase energy demand or require additional filtration. Suppliers that ignore those conditions risk underperformance and warranty disputes.

Second, UV must provide an advantage over chlorine, ozone, membranes, heat, or other competing technologies. The advantage may be pathogen control, reduced chemical handling, lower disinfection by-product formation, advanced oxidation, production protection, or reuse compliance. UV does not automatically replace chemical residuals or upstream treatment.

Third, the supplier must prove lifecycle reliability. Utilities and industrial plants evaluate replacement availability, energy use, system uptime, validation, service coverage, and compatibility with existing controls. Product price matters, but an inexpensive system with narrow validation or weak service can create a higher total cost through downtime and compliance risk.

The strongest growth opportunity is therefore not undifferentiated UV hardware. It lies in validated drinking-water reactors, energy-controlled wastewater systems, water-reuse and advanced-oxidation platforms, industrial process applications, certified UV-C LED systems, and recurring installed-base services. Companies that combine application engineering, regulatory evidence, digital monitoring, and local support will capture more customer spending than suppliers competing only on lamp wattage or initial equipment cost.

 

UV Disinfection Equipment Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 5.34 Billion
Revenue Forecast in 2032	USD 11.30 Billion
Overall Growth Rate	CAGR of 11.3% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
By Component	UV Lamps; Quartz Sleeves; Ballasts/Controllers; Reactor Chambers; Others
By Application	Water & Wastewater Disinfection; Air Disinfection; Surface Disinfection; Food & Beverage Disinfection
By End User	Municipal; Industrial; Healthcare; Commercial; Residential
By Geography	North America; Europe; Asia-Pacific; Latin America; Middle East & Africa
Customization Option	Available upon request